Education Research Clinical Trials Patient Care Delivery Health Services
DELIVERING THE
PROMISE
Scottsdale
C U R E
Corr i d o r
2015 CURE CORRIDOR UPDATE
City of Scottsdale Economic Development
Explore more at
ChooseScottsdale.com/CureCorridor
>
An overview of bio-life science assets on the Scottsdale Cure Corridor
The City of Scottsdale is proud to be home to a vast array of assets that contribute to the success of healthcare and bioscience activities in the region. From
education and research, to clinical trials and patient care delivery, it is happening right here in Scottsdale.
F o r a d d i t i o n a l i n f o r m a t i o n v i s i t C h o o s e S c o t t s d a l e . c o m / C u r e C o r r i d o r.
EDUCATION
RESEARCH
Arizona State University (ASU)
Department of Biomedical
Informatics (BMI) at Mayo Clinic
Array Therapeutic
bmi.asu.edu
The ASU Department of Biomedical Informatics is committed
to advancing the science and technology of biomedical
informatics by influencing policy and improving individual
and population health. The department provides leadership
in research and development, education, community
engagement and service.
Arizona Technology Enterprises
(AzTE) at SkySong
www.azte.com
Arizona Technology Enterprises (AzTE) is the exclusive
intellectual property management and technology transfer
organization for Arizona State University. AzTE works with
faculty, investors and industry partners to speed the flow
of innovation from research laboratory to the marketplace.
From revolutionizing the management and treatment of
epilepsy to creating a family of software components used
to expand CPU processing capacity in iSCSI SAN, AzTE’s
startups are taking off.
Mayo Medical School – Arizona Campus
www.mayo.edu/education
Mayo Medical School, based in Rochester, Minn., is
collaborating with Arizona State University to expand Mayo’s
medical school nationally, including a campus here in the
Phoenix metropolitan area. Students at all Mayo locations
will have the option of completing an ASU master’s degree
in the science of health care delivery as they earn Mayo
medical degrees. The master’s degrees components include
social and behavioral determinants of health, health care
policy, health economics, management science, biomedical
informatics, systems engineering and value principles of
health care.
Scottsdale Community College
www.scottsdalecc.edu
Scottsdale Community College (SCC), a two-year college,
is one of 10 colleges in the Maricopa Community College
District. Its mission is to improve the quality of life in its service
communities by providing challenging, supportive and
distinctive learning experiences. SCC offers a compendium
of courses and degrees in bioscience related topics, and
is a Maricopa leader in math and science instruction and
undergraduate science research.
SkySong
www.skysong.asu.edu
ASU SkySong impacts local, state and international
economies by engaging the university with businesses and
governments to drive economic development and corporate
engagement. Under the Office of Knowledge Enterprise
Development, the research arm of the university, ASU
SkySong is committed to advancing bioscience research and
innovation, creating linkages to the biomedical community,
and producing outstanding graduates to the field.
Spear Education
www.speareducation.com
An innovative dental education company, the Spear Education
facility has a masterful curriculum, gifted instructors and an
ideal environment for advanced learning to serve dentists,
those dedicated to the pursuit of clinical excellence that
transforms their practices and the lives of their patients.
From lecture to hands-on training, the 65,000 square-foot
Spear Campus facility provides a fully engaging learning
experience. Members attend seminars in a state-of-art 300
person lecture hall, while experiencing firsthand the latest
innovations in dental technology in the Spear laboratory.
www.arraytherapeutic.com
Array Therapeutic is pioneering research for the application
of ultrasound to stimulate biological cells for the treatment of
pain and neural disorders. Their mission is to find new ways
in which energy waves can be used to stimulate healing,
reduce pain and to develop products based on these findings
that will contribute to health and wellbeing of people.
The Ben & Catherine Ivy Foundation
www.ivyfoundation.org
The Foundation funds patient-focused research on gliomas,
a type of brain tumor. Having invested more than $50 million
in brain cancer research since 2005, its ultimate goal is
to cure brain cancer. Current efforts focus on improving
diagnostics and treatment that will lead to the doubling of
life expectancy for patients with brain cancer within the
next seven years. The Ivy Foundation is the largest privately
funded brain cancer research foundation in North America.
Blood Systems, Inc.
www.bloodsystems.org
Blood Systems, one of the nation’s oldest and largest
non-profit community blood service providers, operates
community blood centers serving nearly 600 hospitals in
18 states, four high-volume donor testing laboratories,
biological products distribution services, a quality consulting
group and a world-renowned transfusion medicine research
institute.
Wearable Robotics Association (WearRA)
www.wearablerobotics.com
The Wearable Robotics Association (WearRA) is the only
professional association dedicated to the entrepreneurs,
businesses and academics fueling the wearable robotics
industry. WearRA provides a forum for the wearable robotics
community to share ideas and collaborate in a way that
expands and improves the ecosystem of technologies and
participants.
Radiant Research
www.radiantresearch.com
Radiant Research is a comprehensive clinical research and
development company serving the biopharmaceutical and
medical device industry. Their clinical research centers
provide a critical service to biopharmaceutical companies by
conducting the clinical research protocol and collecting the
data necessary to support the safety and efficacy of the drug
company’s product to the FDA.
HonorHealth Research Institute
www.HonorHealth.org
The HonorHealth Research Institute is where world-class
care and ground breaking research meet to benefit local
patients. Leading researchers, community physicians and
clinical teams work together to develop new therapies, as
well as provide innovative care and treatments close to
home. Characteristics that make HonorHealth Research
Institute unique include a focus on translating medical
innovations into solutions, a drug development scholar
program, recognition in the area of ‘precision medicine’, and
collaboration and education. Numerous clinical trials are
always underway at HonorHealth Research Institute in areas
such as oncology, cardiovascular, bariatrics, trauma and
orthopedics/neurology.
CLINICAL TRIALS
Imaging Endpoints
www.imagingendpoints.com
Imaging Endpoints is a leader in the integration of imaging
into clinical development to accelerate outcomes and
improve success. They specialize in helping companies
develop and incorporate the best imaging methodologies
into their translational studies and clinical trial programs,
such as the Rapid Detection and Assessment of Response
program (RADAR). RADAR is designed to accelerate product
development by integrating new, more powerful imaging
technologies into translational studies and clinical trials.
Provista Diagnostics
www.globalmed.com
GlobalMed, a privately held company headquartered
in Scottsdale, is a leader of telemedicine companies
transforming healthcare globally by developing and
integrating secure, efficient health delivery systems
that improve access and quality of care, while reducing
unnecessary costs.
www.provistadx.com
Provista Diagnostics develops and commercializes
breakthrough, easy to administer blood based diagnostic
tests for early oncology-related disease state recognition
and detection purposes. Its focus is on oncology-related
diagnostics where a significantly high, unmet clinical need for
such testing products exists, and develops these diagnostic
technologies at its CLIA accredited, GLP compliant laboratory
facility based in Scottsdale, Arizona.
Lattice Biologics
Arizona Breastnet LLC
GlobalMed
www.latticebiologics.com
Lattice is an emerging personalized/precision medicine
leader in the field of cellular therapies and tissue engineering,
with a focus on bone, skin, and cartilage regeneration.
Lattice develops and manufactures biologic products to
domestic and international markets.
Regenesis Biomedical
www.regenesisbio.com
Regenesis Biomedical is an Arizona-based medical device
company dedicated to improving human welfare through
the research, design, manufacture, and sale of energybased medical products and services that alleviate pain,
restore health, and improve quality of life. As a company we
value pioneering spirit, excellence, respect, family, integrity,
compassion and dedication.
Neuromuscular Research Center
www.nrcaz.com
Neuromuscular Research Center is dedicated to the diagnosis
and treatment of patients with neuromuscular and other
neurological disorders. The center performs electromyogram
(EMG) and nerve conduction studies, muscle and nerve
biopsies, immunotherapy and infusions and clinical research
trials with biologics.
www.breastnet.com
Arizona Breastnet is a full service breast diagnostic center in
Scottsdale, Arizona. Their priority is to support today’s modern
woman who takes charge of her own health and wants to be
informed, educated and in control of her personal healthcare
decisions. They are on a mission to change the face of breast
care.
Translational Drug Development (TD2)
www.td2inc.com
Translational Drug Development (TD2) provides innovative
services for oncology-focused biopharmaceutical companies.
TD2 is uniquely positioned to support improved and accelerated
development of medicines for life-threatening diseases. TD2
applies rigorous and high-throughput translational preclinical
development, combined with regulatory affairs expertise,
to customize clinical trial design and execution. TD2’s suite
of capabilities encourages the timely selection of patient
populations most likely to benefit from new medicines, and the
rapid identification of clinically significant endpoints. TD2 is
committed to reducing the risks and uncertainty inherent in the
drug development process and to the acceleration of patient
access to promising treatments. TD2 is a for-profit subsidiary of
the non-profit Translational Genomics Research Institute (TGen).
www.tgen.org
Virginia G. Piper Cancer Center at
HonorHealth
www.HonorHealth.org/cancer
HonorHealth’s Virginia G. Piper Cancer Center Clinical Trials is
one of the nation’s leading centers for Phase I “first in human”
clinical trials of new cancer therapies. A partnership with TGen
(www.tgen.org), the center is known for its work in advanced
and rare cancers. The center continues to accelerate the
development of new therapies for even the most challenging
cancers, giving our community access to new technologies,
hope and for many longer, healthier lives. Success stories
include treating the world’s first patient with Erivedge, a
breakthrough for advanced basal cell cancers and others,
which was approved by FDA in one-third typical time, and the
study of Abraxane/Gemcitabine, a new combination therapy
began at HonorHealth and confirmed in international trials to
extend survival in pancreatic cancer (doubled response from
standard therapy). Virginia G. Piper Cancer Center Clinical
Trials has attracted patients from 48 states and two dozen
countries.
PATIENT CARE
DELIVERY
Pinnacle Oncology
www.azpoh.com
Pinnacle Oncology Hematology is a community-based
medical practice with a concentration on wellness and care of
patients with cancer using a unique model with both a clinical
and research focus. The care and management of patients
with cancer and associated diagnoses is rapidly changing
and evolving. Michael S. Gordon, M.D., a medical oncologist,
is President and CEO of Pinnacle Oncology Hematology and
was recently named medical director for Virginia G. Piper
Cancer Center Clinical Trials at HonorHealth.
Brain State Technologies
www.brainstatetech.com
Brain State Technologies offers the leading breakthrough
neuro-technology for optimizing brainwave function, in
turn improving overall cognitive, emotional and physical
performance. Improving brain function has shown to help
with injuries, disorders, stress, pain, anxiety, sleeplessness,
addictive dependencies, challenges to learning and
performance.
CVS Health
www.carehealth.com
CVS Health is dedicated to helping people on their path to
better health as the largest integrated pharmacy company
in the United States. Through the company’s more than 7,500
CVS/pharmacy stores; its leading pharmacy benefit manager
serving more than 60 million plan members; and its retail
health clinic system, the largest in the nation with more than
600 MinuteClinic locations, it is a market leader in mail order,
retail and specialty pharmacy, retail clinics, and Medicare
Part D Prescription Drug Plans. As a pharmacy innovation
company with an unmatched breadth of capabilities, CVS
Health continually strives to improve health and lower costs
by developing new approaches such as its unique Pharmacy
Advisor program that helps people with chronic diseases such
as diabetes obtain and stay on their medications.
HealthSouth Scottsdale
Rehabilitation Hospital
www.healthsouthscottsdale.com
HealthSouth Scottsdale Rehabilitation Hospital is a 60-bed
inpatient rehabilitation hospital that offers comprehensive
inpatient, outpatient and home health rehabilitation services
designed to return patients to leading active and independent
lives. In addition to caring for general rehabilitation diagnoses
such as neuro, orthopedic, cardiac, pulmonary, and
oncology, HealthSouth Scottsdale Rehabilitation Hospital has
specialized inpatient programs for stroke, brain injury, burn,
and Parkinson’s disease.
Mayo Clinic
www.mayoclinic.org/Arizona
Mayo Clinic is a nonprofit worldwide leader in medical care,
research and education for people from all walks of life. The
clinical practice is focused on adult specialty and surgical care
in more than 65 medical and surgical disciplines, supported
by outstanding programs in medical education and research.
McKesson Specialty Health
www.mckesson.com
McKesson Specialty Health, a division of McKesson
Corporation, empowers the community patient care delivery
system by helping community practices advance the science,
technology and quality of care. Through innovative clinical,
research, business and operational solutions, facilitated by
integrated technology systems, they focus on improving
the financial health of their customers so they may provide
the best care to their patients. McKesson Specialty Health
supports more than 3,000 physicians and over 3,100 practices
treating conditions including Oncology, Rheumatology,
Gastroenterology, Urology, Ophthalmology, Dialysis, and
Nephrology.
Plaza Health Care
www.plazahealthcare.com
Plaza Health Care is a 179 bed privately owned facility serving
Arizona and the surrounding States for over 30 years. It
specializes in ventilator and tracheostomy weaning, inpatient
dialysis, and rehabilitation.
Primus Pharmaceuticals
www.primusrx.com
Primus Pharmaceuticals develops innovative low-risk,
fast-to-market prescription medications that are patented
and supported by clinical/scientific research published in
prominent medical journals. Primus promotes its brands using
a national field sales force targeting specialist physicians in
rheumatology, pain management, orthopedics, and obstetrics/
gynecology.
HonorHealth
www.HonorHealth.org
HonorHealth Shea Medical Center is an economic driver and
anchor for the Cure Corridor. The Virginia G. Piper Cancer
Center and HonorHealth Research Institute are both located on
the Shea campus and known for providing precision medicine
through an innovative combination of community physicians,
academic medicine and genomic research. Among its many
medical, educational and research partnerships, HonorHealth
is a primary clinical research site for TGen providing patients
with access to cutting edge technologies.
Health Services
Accolade
www.accolade.com
Accolade is an innovative consumer engagement and
healthcare influence company, dedicated to helping people get
the right care while improving their health care experience and
lowering costs for large employers, payers and Accountable
Care Organizations. The company serves the western half
of the United States from Scottsdale with the services of
Accolade Health Assistants who take the time to get to know
individuals, understanding the context of their health care
decisions, building trust and influencing decisions as they
navigate the complex health care system.
Gobiquity
www.gobiquity.com
Gobiquity is a dynamic company leveraging smartphone
technology to help healthcare professionals detect and prevent
health disorders and chronic diseases, and change lives.
Gobiquity recently published a pediatric vision screener for us
on smart phones. The application “GoCheck Kids” was the
first and only clinical program on a smartphone incorporating
a cloud-based HIPAA-compliant platform.
GoXtudio
www.goxtudio.com
GO XTUDIO, LLC, develops wearable and robotic technologies
that enhance the health, performance and quality of life of our
elderly, physically impaired, athletes both serious and the
not so serious, Military and emergency professionals, and
the rest of us! We strive, based on a thorough understanding
of human physiology, to apply optimally minimal layers of
technology to enhance the person. We take a community
approach working with universities and partner companies
to create and maintain a stream of innovation and
product realization that is inherently low cost and diverse.
NeoLight
www.theneolight.com
NeoLight is a medical device firm that develops incubators
to cure jaundice in newborn babies. NeoLight constructed
two devices, one designed for the United States and a
second, called NeoLight Freedom, that was designed for
underdeveloped countries where power supply is scarce. Both
devices are lightweight, portable, solar powered and utilize
LED lighting, which lasts for more than 20,000 hours and
consumes only five watts of electricity.
Matrix Medical Network
www.matrixforme.com
Dedicated to improving the health and lives of American
seniors, Matrix Medical Networks works on behalf of Medicare
Advantage health plans across the country to outreach to their
members. Using an employee network of specifically trained
Nurse Practitioners, the Matrix clinician visits plan enrollees
in their homes and in nursing facilities to conduct one-on-one
health assessments. The goal of these visits is to assess the
health of the individual as well as review their medications
and living environment and to connect them with necessary
medical and community resources to improve their health
status.“
Magellan Health
www.magellanhealth.com
Headquartered in Scottsdale, Magellan Health is a healthcare
management company that focuses on fast-growing, complex
and high-cost areas of healthcare, with an emphasis on
special population management. Magellan delivers innovative
solutions to improve quality outcomes and optimize the cost of
care for those we serve. Magellan’s customers include health
plans, managed care organizations, insurance companies,
employers, labor unions, various military and government
agencies, third party administrators, consultants and brokers.
Orion Healthcare
www.orionhealth.com
Scottsdale is the North American Center of Excellence of this
major New Zealand software company offering solutions to
healthcare providers and insurance companies.
Systems Imagination
www.systemsimagination.com
Systems Imagination, Inc. (SII) is the world’s first knowledge
evolution network company. Founded by Spyro Mousses, Ph.D.
and Chris Yoo, Ph.D., SII is led by a multidisciplinary team of
scientists, with the mission of developing industrial solutions
to massively accelerate the evolution of scientific knowledge.
Systems Imagination offers access to next generation rapid
learning systems and knowledge evolution network mining
services to empower its clients to transform their ability to
recover, discover, and evolve scientific knowledge.
Theranos
www.theranos.com
Theranos is a privately held health technology and medical
laboratory services that provides blood tests. Theranos’
patented technology can analyze samples as small as 1/1,000
the size of the typical blood draw.
ZocDoc
www.zocdoc.com
Scottsdale is the second national center for ZocDoc, a mobile
service allowing consumers to access medical professionals
directly online. Each month, millions of patients use ZocDoc
to find in-network neighborhood doctors, instantly book
appointments online, see what other real patients have to
say, get reminders for upcoming appointments and preventive
checkups, fill out their paperwork online, and more.
Scottsdale
C U R E
19
20
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5
31
Corr i d o r
Hospitals
Academic Institutions
Health Services
9
Pharmaceutical Companies
Research/Clinical Trials
14
Arizona Breastnet LLC
Arizona Center for Fertility Studies Ltd.
Arizona Oncology Associates
Arizona Oncology Services
Arizona State University Department of Biomedical Informatics
Array Therapeutic
Brain State Technologies
Cayenne Medical Inc.
Clinical Technologies Inc.
CVS Health
Global Dental Science
GlobalMed Group
HealthSouth Scottsdale Rehabilitation Hospital
GoXtudio
Ironwood Cancer & Research Centers
Lattice Biologics
Systems Imagination
LabCorp
Mayo Clinic
Mayo Medical School -Arizona Campus
Orthoscan
Provista Diagnostics
HonorHealth
HonorHealth Research Institute
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Scottsdale Medical Imaging
Scottsdale Pediatric Center PC Inc.
Scottsdale Urologic Surgeons Ltd.
Sleep Healthcenters LLC
Spooner Physical Therapy & Hand Rehab P.C.
St. Jude Medical
Translational Drug Development (TD2)
Arizona Oncology
Valley Anesthesiology Consultants Ltd.
Valley Ent P.C.
Virginia G. Piper Cancer Center at HonorHealth
West Pharmaceutical Services
Magellan Health
Accolade
Matrix Medical Network
Primus Pharmaceuticals
Orion Health
ZocDoc
NeoLight
21st Century Oncology
Prismic Pharmaceuticals
Theranos
SkySong, the Scottsdale ASU Innovation Center
GoBiquity
N
13
10
27
32
8
29 4
16
26
24
39
23 3
2
15 1
33
22
Shea Blvd.
38
35
11
30
7
21
45
28
6
17
36
12
Scottsdale Road
41
37
40
33
48
33 27
25 18
34
42
44
47
43
46
Scottsdale’s HonorHealth - Identifying cancer early
and developing patient unique treatment plans
Important collaborations help shape Scottsdale’s
Cure Corridor and impact the community
TD2 plays a critical role in
Pancreatic Cancer Clinical
Trial
Scottsdale’s
Translational
Drug
Development (TD2), the premier Clinical
Research Organizations (CRO) in the United
States specializing in oncology on the
forefront of cancer research was chosen
by PHarmaCyte BioTech to conduct clinical
trials in the U.S. PharmaCyte Biotech, Inc.,
a clinical stage biotechnology company
focused on developing targeted treatments
for cancer and diabetes using its signature
live-cell encapsulation technology, Cellin-a-Box®, announced Oct.15 2015 that
its upcoming clinical trial designed to
determine whether its pancreatic cancer
treatment (Cell-in-a-Box® capsules + lowdoses ifosfamide chemotherapy) can satisfy
a critical unmet medical need for patients
with pancreatic cancer.
TD2 has assumed the lead role and will be
responsible for clinical development plans,
program analysis, medical writing, clinical
management and database development.
PharmaCyte Biotech’s Chief Executive
Officer, Kenneth L. Waggoner, stated,” We
selected TD2 to be the lead CRO because
TD2 is setting the standard for new oncology
drug approvals in the United States. TD2 is
unique in its comprehensive understanding
of oncology clinical development. TD2’s
world renowned experts in science and
medicine have time and again demonstrated
their deep commitment to scientific
discovery and innovation.” q
• New drug treatments, some now
approved, were managed by
TD2 — Abraxane in combination
with gemcitabine for pancreatic
cancer; and Erivedge for basal cell
carcinoma that has spread to other
parts of the body. All were tested
first in Scottsdale at the Virginia G.
Piper Cancer Center Clinical Trials,
a partnership of HonorHealth and
TGen. TD2 managed a cutting-edge
clinical trial conducted by the SideOut Foundation. This exciting trial
involved deep molecular profiling and
proteomic mapping of breast tumors
to prospectively select the best
treatment for that patient. The results
from the first study demonstrated
that 52 percent of patients with
advanced breast cancer received
clinical benefit by addressing the
abnormal proteins in their tumor.
• An example of the high-caliber
business affiliations involving TD2
was the recent $200 million deal
announced between Celgene and
Forma Therapeutics to develop a
new line of anti-cancer drugs. The
collaboration will discover new
medicines and use TD2 to execute
on development from the earliest
preclinical studies to initial Phase I –
first in human – clinical trials. q
Our approach ensures a win-win for
patients and companies alike . . . We are
proud to be an anchor of the Cure Corridor.
Dr. Stephen Gately
President and Chief Executive Officer
TD2
“Mayo Clinic’s presence in Scottsdale has provided the opportunity
for us to serve this community for over 25 years. We are
proud of the many advances made by our physicians
and scientists across our clinical practice, as well as in
education and research. Being a part of the Scottsdale
Cure Corridor is important to Mayo Clinic and will continue
to enhance our mission of caring for the patients in this
community who need us the most, while supporting robust
programs in medical education and scientific research.”
Wyatt W. Decker, M.D., M.B.A
Vice President, Mayo Clinic
CEO for Mayo Clinic in Arizona
Professor of Emergency Medicine,
Mayo Clinic College of Medicine
“Winfield Scott founded Scottsdale as a place
of health and healing more than 125 years
ago. HonorHealth continues to leverage that
innovative spirit to find new ways to improve
and extend the lives of our cancer patients. Our
community physicians and physician scientists
are working together and collaborating with
others across the “Cure Corridor” to find a cure
for a disease that touches so many lives and
families.”
Tom Sadvary
Chief Executive Officer
HonorHealth
Flexibility, choice and value for
community oncology
McKesson Specialty Health makes the community-based
practice stronger. McKesson Specialty Health supports more
than 3,000 physicians and over 3,100 practices. The nearly
1,000 physicians in The US Oncology Network, which is supported by McKesson Specialty
Health, treats more than 750 thousand patients yearly. Arizona Oncology, a practice in The
US Oncology Network, has three locations in Scottsdale along the Cure Corridor. Scottsdale
- Cancer Transplant Institute, Scottsdale Gynecologic Oncology and Scottsdale Medical
Oncology
US Oncology Research is supported by McKesson Specialty Health and The US Oncology
Network, One of the largest community-based oncology research programs in the United
States specializing in Phase I-IV clinical trials, with nearly 225 locations. US Oncology
Research has been involved in more than 1,200 clinical trials, enrolling more than 55,000
patients since inception. For more information about McKesson Specialty Health, please
visit www.mckessonspecialtyhealth.com. q
Why HonorHealth’s research efforts
are unique
Focusing on precision
medicine
There are more than 200 cancers, and
countless treatment options for every type.
Patients don’t have to navigate the cancer
journey alone. Our experts help create a
plan for each patient’s unique needs. At
the HonorHealth Virginia G. Piper Cancer
Center, cancer care is not viewed as a onesize-fits-all approach. Care is tailored to
consider:
• Genetic make-up.
• Family history.
• Response to prior treatments.
• Best treatment for specific cancer types.
• Personal preferences and needs.
Dedication to education and
collaboration
Having established partnerships with
Harvard, Duke, Johns Hopkins, Columbia,
University of The HonorHealth Research
Institute has established partnerships with
Harvard, Duke, Johns Hopkins, Columbia,
University of Pennsylvania, Salk Institute,
TGen, University of Arizona, Arizona State
University and many pharmaceutical and
biotechnology companies. The facility is
“an institute without walls,” says its chief
executive, Mark Slater, PhD.
While working on new treatments today,
the HonorHealth Research Institute also
is ensuring that vital research continues
tomorrow. Thanks to a unique drug
development scholar program, HonorHealth
physicians can receive training in clinical
research.
Translating medical
innovations into solutions
The HonorHealth Research Institute is
committed to accelerating breakthrough
therapies for devastating and debilitating
disorders. These conditions often have no
solutions, leaving patients and their families
without answers and too often without hope.
Virginia G. Piper Cancer Center
provides healing and hope when
needed most
At the HonorHealth Virginia G. Piper
Cancer Center, patients have access
to comprehensive care from leading
oncologists, state-of-the-art diagnosis and
treatment, ground breaking clinical trials and
a wide range of free support services—all in
one convenient location.
For more information, contact
a Cancer Care Coordinator
at 480-323-1339 or
clinical [email protected].
Today, more than 50 percent of all cancers
are cured because of early detection and
innovative treatments.
Whether it’s harnessing the power of the
body’s immune system, using the patient’s
genetic footprint, or introducing the
newest drugs and therapies, Scottsdale’s
HonorHealth is rapidly redefining how the
world treats cancer.
HonorHealth’s experts help each patient
create a plan that works for his or her unique
needs. At the HonorHealth Virginia G. Piper
Cancer Center in Scottsdale, cancer care is
not viewed as a one-size-fits-all approach.
Care is tailored to consider:
• Genetic make-up.
• Family history.
• Response to prior treatments.
• Best treatment for specific cancer types.
• Personal preferences and needs.
• Here, community physicians join
forces with leading physician-scientists
and clinical teams to develop new
and unique therapies for improving the
health and quality of life of their patients.
Benefits of cancer care at HonorHealth
• Initial appointments available within
48 hours.
• Immediate access to the newest
ground breaking treatments.
• Personalized care and support services.
• Creation of the future of cancer care
through clinical trials.
• Navigators that guide the patient’s every
step.
• Interception of cancer before it happens
through genetic counseling and
screening.
• Treatment that is based on genetic
make-up.
• Treatment that harnesses the power of
the immune system.
• Arizona’s most successful stem cell
transplant program.
• Partnerships with the world’s best cancer
providers
and
pharmaceutical
companies.
At HonorHealth, experts are redefining
how the world treats cancer. “Patients
can find innovative care and treatments
close to home,” said Mark Slater, PhD,
HonorHealth vice president of research and
chief executive of HonorHealth Research
Institute. “We also offer help and hope
today and advancements for tomorrow. “
Immunotherapy: Harnessing the power of the
immune system
One of the most promising treatment
options for cancer is immunotherapy. It
stimulates the immune system to recognize
and eliminate cancer cells from the body.
Immunotherapy has much promise because
of its effectiveness and lack of side effects.
The immune system has the capability
to fight off cancer, but it needs to see the
cancer cells first. Immunotherapy treatment
flips the switch on cancer cells so they can
no longer hide, and the immune system can
do its job — attacking and killing cancer
cells. The ground breaking treatment has
demonstrated remarkable results in treating
cancers that have evaded the immune
system and spread out of control.
Hope for Today, Innovation for Tomorrow
A clinical trial is an option for cancer patients
at any stage of their cancer journey. In fact,
it is recommended that a patient seek out a
clinical trial as soon as they are diagnosed.
Patients don’t have to wait until other
treatments have failed to enroll in a trial.
Each clinical trial has specific eligibility
criteria — requirements that patients must
meet before they can participate. The
clinical trials nurse navigator will help the
patient make a decision.
“The research done at our clinical trials is
remarkable, and it benefits our community—
and beyond,” said Dr. Slater, noting that
Virginia G. Piper Cancer Center Clinical
Trials has seen patients from 48 states and
two dozen countries.
“Some of the patients seen in the clinical
trials program have not responded to
standard care and have been told they
only have 12 weeks to live. Despite this,
each week, I hear about patients who are
celebrating their one, two and three-year
anniversaries. They’re attending weddings
and having birthdays. We’re able to extend
their quantity and quality of life,” Dr. Slater
said.
Genes and Cancer
Genetic counseling can empower patients
with information about their cancer risks,
Mayo Medical School receives state
licensure for Arizona branch campus
Mayo Medical School announced in May
2015 that its planned expansion in Scottsdale,
has received licensure by the Arizona State
Board for Private Postsecondary Education,
the group responsible for regulating private
postsecondary degree-granting institutions
within the state of Arizona.
“This is a major milestone in our journey
to open a full four-year branch campus of
Mayo Medical School in Scottsdale,” says
Wyatt Decker, M.D., CEO of Mayo Clinic in
Arizona. Earlier this month, Mayo Medical
School leaders announced they had also
received endorsement for the expansion from
the Liaison Committee for Medical Education
(LCME), the accrediting body for medical
education.
While many experts wonder if medical
schools across the country are doing enough
to prepare graduates for the challenges of an
evolving health care system, Dr. Decker notes
that the medical school — planned to open in
2017 — won’t rest on conventional physician
training.
“The reality is that most medical schools
are teaching the same way they did 100 years
ago,” Dr. Decker said in a recent Wall Street
Journal article. “It’s time to blow up that
model and ask, ‘What must we do to train
tomorrow’s doctors?’”
One tool that will be woven into the school’s
transformative education is a four-year
Science of Health Care Delivery curriculum
jointly developed with Arizona State University
(ASU), along with innovative online learning
modules. As Mayo medical students master
subjects such as systems engineering, health
care policy and biomedical informatics, they
will become the first in the nation to receive
a certificate in the Science of Health Care
Delivery, jointly conferred by Mayo Medical
School and ASU, along with their medical
degree. Students will also have the personal
option of completing a master’s degree in the
Science of Health Care Delivery through ASU.
q
the likelihood that their family’s history of
cancer is hereditary, and options for genetic
testing.
The ability to use a patient’s genetic
makeup for a more targeted treatment plan
is a strength of the HonorHealth Virginia
G. Piper Cancer Center. The goal of our
genetic program is to prevent cancer, or to
detect it as early as possible by identifying
individuals at increased risk. We also
have emerging opportunities to connect
treatment the patient’s genetic makeup.
Cancer Transplant Institute
The HonorHealth Cancer Transplant
Institute, located at the Virginia G. Piper
Cancer Center, cares for patients with blood
cancers such as leukemia, lymphoma and
multiple myeloma.
The patient’s stem cell transplant will meet
the high standards mandated by FACT, the
Foundation for the Accreditation of Cellular
Therapy. The Cancer Transplant Institute is
accredited by FACT for adult transplants.
The institute is also an accredited member
of the National Marrow Transplant Program,
a prestigious program that boasts a registry
of 11 million donors and organizations from
around the world. This means the patient
has access to the most comprehensive list
of donors, if one is needed for a stem cell
transplant.
Clinical research
recognition
• In October 2015, the FDA fast-tracked
approval of a new pancreatic cancer drug
treatment, Onivyde, to treat advanced
pancreatic cancer.
• In September 2013, the FDA approved
the combination of Abraxane and
Gemcitibine to treat advanced pancreatic
cancer. This is now the standard of care.
• Erivedge, the first drug to receive
expedited FDA approval for treating
inoperable basal cell carcinoma, went
from Phase I clinical trials at our cancer
center to FDA approval in five years, half
the time it typically takes for a drug to be
approved.
• RADAR
(Rapid
Detection
and
Assessment of Response) is a one-of a-kind rapid cancer detection program
developed
through
collaboration
between local physicians, HonorHealth’s
Research Institute and the Virginia G.
Piper Cancer Center.
• In November 2015, TGen received a $12
million grant from Stand Up to Cancer.
The goal: To double the survival of patients
with pancreatic cancer. HonorHealth is
part of this dream team — we’re the only
clinical trial site in Arizona for this effort.
• We are one of the original Dream Team
sites for cancer research by Stand Up
to Cancer, making our center the only
one in the Southwest participating as
a collaborator in the $18 million SU2C
pancreatic cancer Dream Team grant.
• Our researchers identified a way to predict
which patients with small-cell lung cancer
may
be
resistant
to
first-line
chemotherapy. The discovery is critical
because patients with small-cell lung
cancer often do not get a second chance
at therapies to combat the aggressive
form of cancer.
• We were the first site in the world for
clinical trials of a drug called OSI-906 to
combat adrenocortical carcinoma, a rare
but deadly cancer that attacks the
adrenal glands.
• We were the world’s first clinical trials site f
or NMS-1286937, a new drug designed
to stop cancer from spreading by
preventing the process of cell division.
• We’re accelerating promising new cancer
treatments through the study of cancer
genetics thanks to partnerships with the
Translational
Genomics
Research
Institute, a leader in developing
treatments for complex diseases
and genetic studies, as well as leading
pharmaceutical companies, biotech
firms and academic universities.
For more information about cancer
programs and services available at
HonorHealth, contact one of our nurse
navigators at 480-323-1339 or visit
honorhealth.com/medical-services/
cancer-care. q
Scottsdale’s Theranos - Wins Arizona
Bioscience Company of the Year
Elizabeth Holmes
Founder and CEO of Theranos
Theranos - A major consumer healthcare
innovator shaping the future of lab testing
planted a significant flag at SkySong, the ASU
Scottsdale Innovation Center in late 2014.
Headquartered in Palo Alto, Theranos,
Inc. is a consumer health care technology
company. Theranos’ clinical laboratory offers
comprehensive laboratory tests from smaller
samples at unprecedented low prices.
Founded in 2003 by Elizabeth Holmes,
Theranos’ mission is to make actionable
health information accessible to people
everywhere in the world at the time it
matters, enabling early detection and
intervention of disease, and empowering
individuals with information to live the lives
they want to live.
The company is also leading transparency
in lab testing by committing to FDA review
all of its laboratory developed tests and
publishing its prices, lab proficiency testing
scores, customer satisfaction scores, guest
visit times, and more.
“When one of our Arizona bioscience
companies achieves great success, it is
cause for celebration across the entire life
sciences community,” said AZBio President
and CEO Joan Koerber-Walker. “The
Arizona Bioscience Company of the Year
award recognizes the bioscience company
whose Arizona-based operations did the
most to transform the world during the last
12 months.” q
PEOPLE MAKING THE DIFFERENCE
Dr. Michael Gordon Virginia G. Piper Cancer Center
Dr. Mark Slater
HonorHealth
Dr. Keith Stewart
Mayo Clinic, Arizona
Dr. Stephen Gately TD2
Dr. Wyatt Decker
Mayo Clinic, Arizona
Dr. Ron Korn
HonorHealth Research
Mayor W.J. “Jim” Lane City of Scottsdale
Dr. Michele Halyard
Dean of Mayo Medical School, Arizona
Tom Sadvary, CEO
HonorHealth
WATCH THE CURE CORRIDOR VIDEO ONLINE
a t
C h o o s e S c o t t s d a l e . c o m / M e d i a
Scottsdale’s bio-life science industry represents
13%
Scottsdale
C U R E
Corr i d o r
of the Phoenix
Metro Area
Bio-life Science
industry
Average
Salary
$59,557
3.4%
Growth Rate
Projected to
2025
Source: EMSI November 2015
FOLLOW US ON TWITTER
@SCOTTSDALEECDEV and #CURECORRIDOR
For information regarding the Cure Corridor, contact:
City of Scottsdale Economic Development
3839 North Drinkwater Blvd. | 2nd Floor
Scottsdale, AZ 85251
Phone: 480-312-7989
E-mail: [email protected]
www.ChooseScottsdale.com